NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/24/2026 15:11
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization31.01 mln
Float13.73 mln
Earnings Date08/06/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
37.63
Highly suspicious
Relative Strength
87
/ 100
Strongly outperforming
Debt / Equity
2.20
Very high leverage
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Daré Bioscience Inc. is a San Diego-based company founded in 2015 that focuses on developing medical treatments for women's health, including contraception, fertility, menopause, pelvic pain, and vaginal and sexual health. Its marketed product, XACIATO, is an antibacterial gel used to treat bacterial vaginosis, while its broad pipeline includes hormone-free contraceptives, pain relief treatments, menopause therapies, and solutions for HPV-related conditions. The company also pursues innovations in preterm birth prevention, fertility support, and non-hormonal contraception for both men and women.
